GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BrightPath Biotherapeutics Co Ltd (TSE:4594) » Definitions » Cash Flow from Discontinued Operations

BrightPath Biotherapeutics Co (TSE:4594) Cash Flow from Discontinued Operations : 円0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is BrightPath Biotherapeutics Co Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

BrightPath Biotherapeutics Co's cash flow from discontinued operations for the three months ended in Dec. 2023 was 円0.00 Mil. It means BrightPath Biotherapeutics Co received 円0.00 Mil from the sale of part of business quarterly. BrightPath Biotherapeutics Co's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Dec. 2023 was 円0.00 Mil.

BrightPath Biotherapeutics Co Cash Flow from Discontinued Operations Historical Data

The historical data trend for BrightPath Biotherapeutics Co's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BrightPath Biotherapeutics Co Cash Flow from Discontinued Operations Chart

BrightPath Biotherapeutics Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial Premium Member Only - - - - -

BrightPath Biotherapeutics Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BrightPath Biotherapeutics Co Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BrightPath Biotherapeutics Co Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of BrightPath Biotherapeutics Co's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

BrightPath Biotherapeutics Co (TSE:4594) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BrightPath Biotherapeutics Co Ltd (TSE:4594) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
TSE:4896 TSE:4583 TSE:4564 TSE:4888 TSE:4588 TSE:2385 TSE:4598 TSE:7776 TSE:4891 TSE:2370 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
2-2-4 Kojimachi, Kojimachi Central Building 7th Floor, Chiyoda-ku, Tokyo, JPN
Website
https://www.brightpathbio.com
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.

BrightPath Biotherapeutics Co (TSE:4594) Headlines

No Headlines